Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
0 structures for Q65999
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|
No variants for Q65999
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q65999 | |||||
No associated diseases with Q65999
No regional properties for Q65999
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q65999 | |||
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| host cell plasma membrane | The plasma membrane surrounding a host cell. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| viral envelope | The lipid bilayer of a virion that surrounds the protein capsid. May also contain glycoproteins. |
| virion membrane | The lipid bilayer surrounding a virion. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| host cell surface receptor binding | Binding to a receptor on the host cell surface. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| viral entry into host cell | The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm. |
| virion attachment to host cell | The process by which a virion protein binds to molecules on the host cellular surface or host cell surface projection. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MLSYQDKAGA | FYKDNARANS | TKLSLVTEEH | GGRRPPYLLF | VLLVLLVGIL | ALLAITGVRF |
| 70 | 80 | 90 | 100 | 110 | 120 |
| HQVSTSNMEF | SRLLKEDMEK | SEAVHHQVID | VLTPLFKIIG | DEIGSRLPQK | LNEIKQFILQ |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KTNFFNPNRE | FDFRDLHWCI | NPPSKVKVNF | TNYCESIGIR | KAIASAANPI | LLSALPGGRS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DIFPPHRCSG | ATTSVGKVFP | LSVSLSMSLI | SRTSEIINML | TAISDGVYGK | TYLLAPDDIE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| REFDTQEIRV | FEIGFIKRWL | NDMPSLQTTN | YMVLPENSKA | KVCTIAVGEL | TLASLCVEES |
| 310 | 320 | 330 | 340 | 350 | 360 |
| TVLLYHDSSG | SQDGILVVTL | GIFGTTPMDH | IEEVIPVAHP | SMEKIHITNH | RGFIKDSIAT |
| 370 | 380 | 390 | 400 | 410 | 420 |
| WMVPALASEK | QEEQKGCLES | ACQRKPYPMC | NQTSWEPFGG | RQLPSYGRLT | LPLDASVDLQ |
| 430 | 440 | 450 | 460 | 470 | 480 |
| LNISFTYGPV | ILNGDGMDYY | ESPLLNSGWL | TIPPKNGTIL | GLINKAGRGD | QFTVIPHVLT |
| 490 | 500 | 510 | 520 | 530 | 540 |
| FAPMESSGNC | YLPIQTSQII | DRDVLIESNL | VVLPTQSFRY | VIATYDISRS | DHAIVYYVYD |
| 550 | 560 | 570 | 580 | 590 | 600 |
| PIRTISYTHP | FRLTTKGRPD | FLRIECFVWD | DNLWCHQFYR | FEANIANSTT | SVENLVRIRF |
| SCNRSNP |